Literature DB >> 15613416

The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes.

Michaela Diamant1, Hildo J Lamb, Marcel A van de Ree, Edwin L Endert, Ymte Groeneveld, Michiel L Bots, Piet J Kostense, Jasper K Radder.   

Abstract

Central obesity, insulin resistance, inflammation, as well as vascular changes are common in patients with type 2 diabetes. In this study we assessed the relationship among stiffness of the carotid artery, visceral fat, and circulating inflammatory markers in type 2 diabetic subjects. Carotid stiffness, quantified as the distensibility coefficient (DC), was measured by ultrasound in asymptomatic, normotensive patients with uncomplicated, well-controlled type 2 diabetes and in controls. Body fat distribution was quantified by magnetic resonance imaging. In patients, the carotid DC was inversely associated with visceral fat area (r = -0.660; P = 0.005) and plasma levels of C-reactive protein (CRP; r = -0.687; P = 0.002), but most strongly with plasma IL-6 (r = -0.766; P < 0.001). In multivariate analysis, the association between DC and visceral fat disappeared after adjustment for CRP and IL-6. Correction for age, body mass index, blood pressure, glycosylated hemoglobin, or fasting plasma glucose did not affect the association between carotid DC and inflammatory markers. Thus, carotid stiffness is associated with visceral obesity in patients with uncomplicated type 2 diabetes, but this association seems to be mediated by circulating IL-6 and CRP, of which IL-6, at least in part, originates from adipose tissue and stimulates hepatic CRP production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15613416     DOI: 10.1210/jc.2004-1579

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  Characterization of the cytokine expression profiles of the aorta and liver of young tumor necrosis factor alpha mutant mice.

Authors:  Yanrong Sun; Miao Yin; Liang Zhang; Jie Pan
Journal:  Mol Cell Biochem       Date:  2012-03-10       Impact factor: 3.396

2.  Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification.

Authors:  Jonathan Golledge; Rumal Jayalath; Lisa Oliver; Adam Parr; Leon Schurgers; Paula Clancy
Journal:  Atherosclerosis       Date:  2007-08-06       Impact factor: 5.162

Review 3.  The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.

Authors:  Michaela Diamant; Maarten E Tushuizen
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

4.  The relationship between low bone mass and metabolic syndrome in Korean women.

Authors:  D-K Hwang; H-J Choi
Journal:  Osteoporos Int       Date:  2009-06-30       Impact factor: 4.507

Review 5.  Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis.

Authors:  Eva Dolezelova; Evan Stein; Giuseppe Derosa; Pamela Maffioli; Petr Nachtigal; Amirhossein Sahebkar
Journal:  Br J Clin Pharmacol       Date:  2017-03-10       Impact factor: 4.335

6.  Impact of central obesity on the estimation of carotid-femoral pulse wave velocity.

Authors:  Marco Canepa; Majd AlGhatrif; Gabriele Pestelli; Rohan Kankaria; Sokratis Makrogiannis; James B Strait; Claudio Brunelli; Edward G Lakatta; Luigi Ferrucci
Journal:  Am J Hypertens       Date:  2014-03-17       Impact factor: 2.689

7.  Abdominal fat distribution and carotid atherosclerosis in a general population: a semi-automated method using magnetic resonance imaging.

Authors:  Amir Reza Radmard; Hossein Poustchi; Leila Ansari; Faezeh Khorasanizadeh; Ali Yoonessi; Amir Pejman Hashemi Taheri; Mohammad Sadegh Rahmanian; Elham Jafari; Reza Malekzadeh; Shahin Merat
Journal:  Jpn J Radiol       Date:  2016-03-25       Impact factor: 2.374

8.  Large artery stiffening with weight gain in humans: role of visceral fat accumulation.

Authors:  Jeb S Orr; Christopher L Gentile; Brenda M Davy; Kevin P Davy
Journal:  Hypertension       Date:  2008-05-05       Impact factor: 10.190

9.  Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition.

Authors:  Mathijs C Bunck; Michaela Diamant; Bjorn Eliasson; Anja Cornér; Rimma M Shaginian; Robert J Heine; Marja-Riitta Taskinen; Hannele Yki-Järvinen; Ulf Smith
Journal:  Diabetes Care       Date:  2010-04-27       Impact factor: 19.112

10.  Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin.

Authors:  Janet E Digby; Eileen McNeill; Oliver J Dyar; Vincent Lam; David R Greaves; Robin P Choudhury
Journal:  Atherosclerosis       Date:  2009-08-31       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.